Document:

Exhibit 10.52

 

ABBOTT LABORATORIES

RESTRICTED STOCK UNIT AGREEMENT

 

This Agreement made «DateAwded»
(the “Grant Date”), between Abbott Laboratories, an Illinois corporation (the “Company”),
and «FirstMILast» (the “Employee”), for
the grant by the Company to the Employee of a Restricted Stock Unit Award under
the Company’s 1996 Incentive Stock Program (the “Plan”).  This Agreement incorporates and is subject to
the provisions of the Program.  Terms
used herein shall have the same meaning as in the Program, and in the event of
any inconsistency between the provisions herein and the provisions of the
Program, the Program shall control.

 

1.             Grant
of Units.  Pursuant to action of the
Compensation Committee of the Board of Directors of the Company, and in
consideration of valuable services heretofore rendered and to be rendered by
the Employee to the Company and of the agreements hereinafter set forth, the
Company has granted to the Employee «NoShares12345» restricted stock units (the
“Restricted Stock Units” or “Units” as used herein), representing the right to
receive an equal number of common shares of the Company on the Delivery
Date.  The “Delivery Date” of the shares
(as defined in Sections 3, 4 and 5 below) shall be the respective dates on
which the common shares of the Company shall be payable to the Employee after
the Restriction (as defined in Section 2 below) on such Units lapse.  Unless indicated otherwise, the shares of
stock shall be delivered in an equal number of shares (subject to rounding) as
of each Delivery Date, if there is more than one Delivery Date applicable.  The shares shall be issued from the Company’s
available treasury shares.  Prior to the
Delivery Date(s), (a) the Employee shall not be treated as a shareholder
as to those shares, and shall only have a contractual right to receive them,
unsecured by any assets of the Company or the subsidiaries; (b) the
Employee shall not be permitted to vote the Restricted Stock Units; and (c) the
Employee’s right to receive such shares will be subject to the adjustment
provisions relating to mergers, reorganizations, and similar events set forth
in the Plan.  The Restricted Stock Units
shall be subject to all of the restrictions hereinafter set forth.  The
Employee shall be permitted to receive cash payments equal to the dividends and
distributions paid on shares of stock (“Dividend Equivalents”) (other than
dividends or distributions of securities of the Company which may be issued
with respect to its shares by virtue of any stock split, combination, stock
dividend or recapitalization) to the same extent and on the same date as if
each Unit were a share of stock, provided, however, that no Dividend
Equivalents shall be payable to or for the benefit of the Employee with respect
to dividends or distributions the record date for which occurs on or after
either (i) the Employee has forfeited the Restricted Stock Units or (ii) the
restrictions on the Restricted Stock Units have lapsed.

 

2.             Restriction.  Until the restriction imposed by this Section 2
(the “Restriction”) has lapsed pursuant to Section 3, 4 or 5 below, the
Units shall not be sold, exchanged, assigned, transferred, pledged or otherwise
disposed of, and shall be subject to forfeiture as set forth in Section 7
below.

 

3.             Lapse
of Restriction by Passage of Time. 
During employment, the Restriction on one-third of the total number of
Units (rounded up) will lapse and have no further force on the first
anniversary of the Grant Date; the Restriction on an additional one-third of
the total number of Units (rounded up) will lapse and have no further force on
the second anniversary of the Grant Date; and the Restriction on the remaining
Units will lapse and have no further force on the third anniversary of the
Grant Date.  Subject to Sections 4, 5 and
6 below, Units with respect to which the Restriction has lapsed shall be paid
in the form of common shares of the Company on the first, second and third
anniversaries of the date of grant (each, a “Delivery Date”).

 

4.             Lapse
of Restriction Due to Retirement.  Upon
the Employee’s termination of employment due to retirement, the Units shall be
settled in the form of common shares of the Company on the Delivery Dates set
forth in Section 3 above occurring after the date of such retirement as if
the Employee had remained employed on such Delivery Dates.

 

1

 

5.             Lapse
of Restriction by Death or Disability. 
The Restriction shall lapse and have no further force or effect upon the
Employee’s death or disability.  Any
Units that have not previously been paid out on a Delivery Date set forth in Section 3
above shall be settled in the form of Company common stock on the date of death
or disability, as the case may be.

 

6.             Forfeiture
of Units.  In the event of
termination of the Employee’s employment with the Company, other than under the
circumstances described in Sections 4 or 5 above, (including without limitation
due to the Employee’s voluntary resignation (other than due to retirement) or
involuntary discharge for cause), any Units with respect to which the
Restriction has not lapsed as of the date of termination, shall be forfeited as
of the date of termination, without consideration to the Employee or his
executor, administrator, personal representative or heirs (“Representative”), provided,
however, that in the event that the Employee is involuntarily discharged
by the Company or its subsidiaries other than for cause, the Company shall have
the authority (but not the obligation) to act, in its sole discretion, to
accelerate the lapse of Restriction set forth in Section 3 above and to
cause any Units that have not previously been paid out on a Delivery Date set
forth in Section 3 above to be settled in the form of Company common stock
on the date of such involuntary discharge.  The term discharge “for cause” shall have the
meaning given that term by Section 10.

 

7.             Withholding
Taxes.  The delivery of the shares
pursuant to Section 3, 4, 5 or 6 above shall be conditioned on the Company
providing for the automatic withholding of shares to cover any taxes as may be
required to be withheld by US federal, state, local or local law with respect
to such lapse or delivery.

 

8.             Rights
Not Enlarged.  Nothing herein confers
on the Employee any right to continue in the employ of the Company or of any of
its subsidiaries.

 

9.             Succession.  This Agreement shall be binding upon and
operate for the benefit of the Company and its successors and assigns, and the
Employee and his Representative.

 

10.           Discharge
for Cause.  The term discharge “for
cause” shall mean termination by the Company of the Employee’s employment for (A) the
Employee’s failure to substantially perform the duties of his employment (other
than any such failure resulting from the Employee’s disability); (B) material
breach by the Employee of the terms and conditions of his employment; (C) material
breach by the Employee of business ethics; (D) an act of fraud,
embezzlement or theft committed by the Employee in connection with his duties
or in the course of his employment; or (E) wrongful disclosure by the
Employee of secret processes or confidential information of the Company or its
subsidiaries.

 

11.           No Contract as of Right.  The
grant of Units under the Plan does not create any contractual or other right to
receive additional Restricted Stock Unit grants or other Plan benefits in the
future.  Nothing contained in this
agreement is intended to create or enlarge any other contractual obligations
between the Company and the Employee. 
Future grants, if any, and their terms and conditions, will be at the
sole discretion of the Compensation Committee. 
Unless expressly provided by the company in writing, any value
associated with the Units granted under the Plan is an item of compensation
outside the scope of the Employee’s employment contract, if any, and shall not
be deemed part of the Employee’s normal or expected compensation for purposes
of calculating any severance, resignation, redundancy, or end-of-service
payments, bonuses, long-service awards, pension or retirement benefits, or similar
payments.

 

12.           Data Privacy.  This
grant of Units shall be interpreted to effect the original intent of the
Company as closely as possible to the fullest extent permitted by applicable
law (including, without limitation, any laws governing data privacy).  If any condition or provision of this option
is invalid,

 

2

 

illegal, or incapable
of being enforced under any applicable law or regulation governing data
privacy, including the privacy laws and regulations of the European economic
area, all other conditions and provisions of the Units shall nevertheless
remain in full force and effect.  By
accepting this grant, the Employee voluntarily acknowledges and consents to the
collection, use, processing and transfer of personal data as described in this
paragraph.  The Employee is not obliged
to consent to such collection, use, processing and transfer of personal
data.  However, failure to provide the
consent may affect the Employee’s ability to participate in the Plan.  The company, its subsidiaries and the
Employee’s employer hold certain personal information about the Employee,
including the Employee’s name, home address and telephone number, date of
birth, social security number or other employee identification number, salary,
nationality, job title, the number of common shares of the Company (if any)
owned by the Employee, whether the Employee is a member of the Board of
Directors of the Company or of any of its subsidiaries, details of all stock
options or any other entitlement to common shares awarded, canceled, purchased,
vested, unvested or outstanding in the Employee’s favor for the purpose of
managing and administering the Plan or this grant (collectively “personal data”).  The Company and/or its subsidiaries will
transfer personal data amongst themselves as necessary for the purpose of
implementation, administration and management of the Employee’s participation
in the Plan, and the Company and/or any of its subsidiaries may each further
transfer personal data to any third parties assisting the Company in the
implementation, administration and management of the Plan.  These recipients may be located in the
European economic area, or elsewhere throughout the world, such as the United
States.  The Employee hereby authorizes
them to receive, possess, use, retain and transfer the personal data, in
electronic or other form, for the purposes of implementing, administering and
managing the Employee’s participation in the Plan, including any transfer of
such personal data as may be required for the administration of the Plan and/or
the subsequent holding of
common shares on the Employee’s behalf to a broker or other third party with
whom the Employee may elect to deposit any common shares acquired pursuant to
the Plan.  The Employee may, when and to
the extent required by applicable data privacy laws, review personal data and
require any necessary amendments to it. 
The employee may, at any time, withdraw the consents herein in writing
by contacting the Company; however, withdrawing the Employee’s consent may
affect the Employee’s ability to participate in the Plan.

 

13.           Payment of Dividend Equivalents.  For purposes of compliance with the
requirements of Internal Revenue Code Section 409A, the specified date of paying
any Dividend Equivalents to which an Employee is entitled under Section 1 is
the year (<<YR1, YR2, YR3, or YR4>>) in which the associated
dividends or distributions are paid on common stock. This Section 13 shall not
create or expand any rights to Dividend Equivalents.

 

14.           Section
409A.  If the Company determines that
this Agreement is subject to 409A of the Internal Revenue Code and fails to
comply with that section’s requirements, the Company may, at the Company’s sole
discretion, amend the Agreement to cause it to comply with Section 409A or
be exempt from Section 409A.

 

IN WITNESS WHEREOF, the Company has caused this Award
to be executed by its duly authorized officer as of the grant date set forth
above.

 

	
  ABBOTT LABORATORIES

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  «FirstMILast»

  

 

3Exhibit
10.1

SEPARATION AGREEMENT

This Separation Agreement (this “Agreement”) is dated as of February 16, 2007 (the “Effective Date”), and is entered into by and between Allos
Therapeutics, Inc., a Delaware corporation (the “Company”),
and David A. DeLong (“Executive” and,
together with the Company, the “Parties”).

RECITALS

WHEREAS,
Executive has been employed by the Company as Vice President, Marketing and
Sales of the Company pursuant to an Employment Agreement, dated as of August
12, 2002, by and between the Company and Executive (the “Employment
Agreement”); and

WHEREAS, the
parties have mutually determined that Executive shall terminate his employment
as Vice President, Marketing and Sales of the Company effective February 16,
2007 (the “Separation Date”), and, in
connection with such separation, the Parties have agreed to settle any and all
related agreements between the Parties and their affiliates in the manner set
forth herein.

NOW THEREFORE,
in consideration of the promises and mutual covenants contained herein, and for
other good and valuable consideration, the receipt and sufficiency of which are
expressly acknowledged, the Parties agree and promise as follows:

Section 1.              Termination. 
Effective on the Separation Date, Executive shall terminate his
employment as the Vice President, Marketing and Sales of the Company.

Section 2.              Termination
Benefits.  Pursuant to Section 10(d) of the Employment Agreement, as
modified herein, upon execution of this Agreement and the full general release
of claims attached hereto as Exhibit B, Executive shall be entitled to receive the
following Severance Benefits:

(a)           Severance Payment. 
The Company shall pay to Executive a one time lump sum
payment equal to six (6) months of Executive’s Base Salary in effect as of the
Separation Date to be paid six (6) months and one (1) day following the
Separation Date.

(b)           Health Insurance.  The Company shall pay the premiums of Executive’s group health insurance
COBRA continuation coverage, including coverage for Executive’s eligible
dependents, for a maximum period of six (6) months following the Separation
Date; provided, however, that (i)
the Company shall pay premiums for Executive’s eligible dependents only for
coverage for which those eligible dependents were enrolled immediately prior to
the Separation Date; and (ii) the Company’s obligation to pay such premiums
shall cease immediately upon Executive’s eligibility for comparable group
health insurance provided by a new employer of Executive.

(c)           Bonus.  
Although the Company is under no obligation to do so, in further
consideration for the promises and agreements contained herein, the Company
agrees to pay Executive a bonus payment equal to $59,217.87 pursuant to the
Company’s Annual Incentive Plan, as in effect for fiscal 2006.

 1
 

 

(d)           Accrued
Obligations.  On the Separation Date, the Company shall pay Executive all earned
but unpaid Base Salary through the Separation Date and reimburse Executive for
any reasonable unreimbursed expenses incurred in accordance with Company policy. 
Additionally, Executive shall be entitled to a payment for all accrued but
unused vacation and sick pay that Executive has accrued through the Separation
Date.

(e)           Stock Options.  Pursuant to Executive’s stock option grant(s)
and the plan(s) governing those grant(s) (the “Plan”), vesting of Executive’s stock options will cease on the
Separation Date.  Any right to exercise
any vested shares or of the Company to repurchase any previously exercised, but
unvested shares, if any, will be as set forth in Executive’s stock option grant
notices, the stock option agreements, and the Plan.

Section 6.              Restrictive
Covenants.  Executive acknowledges that the restrictive covenants set forth in
the Proprietary Information, Inventions, Non-Competition, and Non-Solicitation
Agreement, attached hereto as Exhibit A shall remain in full force and effect
following the Separation Date and Executive further agrees to comply with the
terms of such restrictive covenants.

Section 7.              Release. 
Notwithstanding anything herein to the contrary, Executive shall not be
entitled to any benefits pursuant to this Agreement prior to the time in which
he executes a full general release of claims against the Company and its
affiliates substantially in the form attached hereto as Exhibit B.

Section 8.              Non-Disparagement.  Executive
agrees that, except as required by applicable law, or compelled by process of
law, at any time following the date hereof, neither Executive, nor anyone
acting on his behalf, shall hereafter make any derogatory, disparaging or
critical statement about the Company, the Company’s subsidiaries or affiliates,
or any of the Company’s current officers, directors, employees, or shareholders
or any persons who were officers, directors, employees, or shareholders of the
Company.  The Company agrees that, except as required by applicable law,
or compelled by process of law, neither it, nor anyone acting on its behalf,
shall hereafter make any derogatory, disparaging or critical statement about
the Executive.

Section 9.              Cooperation
by Executive.  Following the Separation Date, Executive will
reasonably cooperate in all reasonable respects with the Company and its
affiliates in connection with any and all existing or future litigation,
actions or proceedings (whether civil, criminal, administrative, regulatory, or
otherwise) brought by or against the Company or any of its affiliates, to the
extent the Company reasonably deems Executive’s cooperation necessary. 
Executive shall be reimbursed for all reasonable out-of-pocket expenses incurred
by his as a result of such cooperation.

Section 10.            Indemnification.  The Company acknowledges that (a) its
by-laws (or those of one or more of its affiliates) contain provisions
indemnifying directors and officers to the fullest extent permitted by
applicable law and (b) Executive is covered by such provisions (as such
provisions are in effect on the Separation Date) to the extent permitted by
applicable law even after the Separation Date with respect to such matters
occurring during the course of 

 2
 

 

Executive’s
employment before the Separation Date, subject to the terms of such by-law
provisions (as such provisions are in effect on the Separation Date).

Section 11.           
Confidentiality of Agreement.  Executive hereby agrees to keep the
terms of this Agreement confidential; provided, that the obligations of
Executive under this Section 11 shall not apply to disclosures required by
applicable law, regulation or order of a court or governmental agency, to
either Executive’s counsel, or to Executive’s immediate family.

Section
12.            Opportunity for Advice. 
By signing this Agreement, Executive acknowledges that with the advice of the
Company, he has had a reasonable opportunity to consider advice from his legal
counsel.  Fully understanding these terms, Executive is entering into this
Agreement knowingly and voluntarily.

Section 13.            Entire
Agreement.  This Agreement represents the entire agreement of the parties with
respect to Executive’s engagement and termination thereof, and supersedes all
prior negotiations, discussions, correspondence, communications, understandings
and agreements between the parties relating to the subject matter of this
Agreement.

Section 14.            Governing
Law.  THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN
ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE APPLICABLE TO CONTRACTS MADE
AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE.

Section 15.            Severability.  In the event
that any provision or portion of this Agreement shall be determined to be
invalid or unenforceable for any reason, in whole or in part, the remaining
provisions of this Agreement shall be unaffected thereby and shall remain in
full force and effect to the fullest extent permitted by law.

Section 16.            Counterparts.  This
Agreement may be executed in one or more counterparts, each of which shall be
deemed an original and all of which together shall be considered one and the
same agreement.

[Remainder of page intentionally left blank.]

 3
 

 

IN WITNESS WHEREOF,
the parties have executed this Agreement effective as of the date and year
first above written.

	
  

  	
  /s/ David A. DeLong

  
	
   

  	
  David A. DeLong

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  ALLOS THERAPEUTICS, INC.

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Jim Caruso

  
	
   

  	
   

  	
  Jim Caruso

  
	
   

  	
  Title:

  	
  Chief Commercial Officer

  

 

 4

 

EXHIBIT A

EXHIBIT A TO EMPLOYMENT AGREEMENT

MANAGER, EXECUTIVE PERSONNEL OR ASSISTANTS’

PROPRIETARY INFORMATION, INVENTIONS,

NON-COMPETITION, AND NON-SOLICITATION AGREEMENT

This Manager,
Executive Personnel or Assistants’ Proprietary Information, Inventions,
Non-competition, and Non-solicitation Agreement (“Agreement”) is made in
consideration for my employment or continued employment by ALLOS THERAPEUTICS, INC.  or its subsidiaries or affiliates
(the “Company”), and the compensation now and hereafter paid to me.  I hereby agree as follows:

1.             NONDISCLOSURE.

1.1          Recognition of Company’s Rights;
Nondisclosure.  At all
times during my employment and thereafter, I will hold in strictest confidence
and will not disclose, use, lecture upon or publish any of the Company’s
Proprietary Information (defined below), except as such disclosure, use or
publication may be required in connection with my work for the Company, or
unless an officer of the Company expressly authorizes such in writing.  I will obtain the Company’s written approval
before publishing or submitting for publication any material (written, verbal,
or otherwise) that relates to my work at the Company and/or incorporates any
Proprietary Information.  I hereby assign
to the Company any rights I may have or acquire in such Proprietary Information
and recognize that all Proprietary Information shall be the sole property of
the Company and its assigns.

1.2          Proprietary Information.  The term “Proprietary Information” shall mean
any and all confidential and/or proprietary knowledge, data or information of
the Company.  By way of illustration but
not limitation, “Proprietary Information” includes (a) trade secrets,
inventions, mask works, ideas, processes, formulas, source and object codes,
data, programs, other works of authorship, know-how, improvements, discoveries,
developments, designs and techniques (hereinafter collectively referred to as “Inventions”);
and (b) information regarding plans for research, development, new
products, marketing and selling, business plans, budgets and unpublished
financial statements, licenses, prices and costs, suppliers and customers; and
(c) information regarding the skills and compensation of other employees
of the Company.  Notwithstanding the
foregoing, it is understood that, at all such times, I am free to use
information which is generally known in the trade or industry, which is not
gained as result of a breach of this Agreement, and my own, skill, knowledge,
know-how and experience to whatever extent and in whichever way I wish.

1.3          Third Party Information.  I understand, in addition,
that the Company has received and in the future will receive from third parties
confidential or proprietary information (“Third Party Information”) subject to
a duty on the Company’s part to maintain the confidentiality of such
information and to use it only for certain limited purposes.  During the term of my employment and
thereafter, I will hold Third Party Information in the strictest confidence and
will not disclose to anyone (other than Company personnel who need to know such
information in connection with their work for the Company) or use, except in
connection with my work for the Company, Third Party Information unless
expressly authorized by an officer of the Company in writing.

1.4          No Improper Use of Information of
Prior Employers and Others.  During
my employment by the Company I will not improperly use or disclose any
confidential information or trade secrets, if any, of any former employer or
any other person to whom I have an obligation of confidentiality, and I will
not bring onto the premises of the Company any unpublished 

 

documents or any property
belonging to any former employer or any other person to whom I have an
obligation of confidentiality unless consented to in writing by that former
employer or person.  I will use in the
performance of my duties only information which is generally known and used by
persons with training and experience comparable to my own, which is common
knowledge in the industry or otherwise legally in the public domain, or which
is otherwise provided or developed by the Company.

2.             ASSIGNMENT OF
INVENTIONS.

2.1          Proprietary Rights.  The term “Proprietary Rights” shall mean all trade secret, patent, copyright, mask work
and other intellectual property rights throughout the world.

2.2          Prior Inventions.  Inventions, if any,
patented or unpatented, which I made prior to the commencement of my employment
with the Company are excluded from the scope of this Agreement.  To preclude any possible uncertainty, I have
set forth on Exhibit A (Previous
Inventions) attached hereto a complete list of all Inventions that I have,
alone or jointly with others, conceived, developed or reduced to practice or
caused to be conceived, developed or reduced to practice prior to the
commencement of my employment with the Company, that I consider to be my
property or the property of third parties and that I wish to have excluded from
the scope of this Agreement (collectively referred to as “Prior Inventions”).  If disclosure of any such Prior Invention
would cause me to violate any prior confidentiality agreement, I understand
that I am not to list such Prior Inventions in Exhibit A but am only to
disclose a cursory name for each such invention, a listing of the party(ies) to
whom it belongs and the fact that full disclosure as to such inventions has not
been made for that reason.  A space is
provided on Exhibit A for such
purpose.  If no such disclosure is
attached, I represent that there are no Prior Inventions.  If, in the course of my employment with the
Company, I incorporate a Prior Invention into a Company product, process or
machine, the Company is hereby granted and shall have a nonexclusive,
royalty-free, irrevocable, perpetual, worldwide license (with rights to
sublicense through multiple tiers of sublicensees) to make, have made, modify,
use and sell such Prior Invention. 
Notwithstanding the foregoing, I agree that I will not incorporate, or
permit to be incorporated, Prior Inventions in any Company Inventions without
the Company’s prior written consent.

2.3          Assignment of Inventions.  Subject to Sections 2.4, and 2.6, I hereby
assign and agree to assign in the future (when any such Inventions or
Proprietary Rights are first reduced to practice or first fixed in a tangible
medium, as applicable) to the Company all my right, title and interest in and
to any and all Inventions (and all Proprietary Rights with respect thereto)
whether or not patentable or registrable under copyright or similar statutes,
made or conceived or reduced to practice or learned by me, either alone or
jointly with others, during the period of my employment with the Company.  Inventions assigned to the Company, or to a
third party as directed by the Company pursuant to this Section 2, are
hereinafter referred to as “Company Inventions.”

2.4          Nonassignable Inventions.  I recognize that, in the event of a
specifically applicable state law, regulation, rule, or public policy (“Specific
Inventions Law”), this Agreement will not be deemed to require assignment of
any invention which qualifies fully for protection under a Specific Inventions
Law by virtue of the fact that any such invention was, for example, developed
entirely on my own time without using the Company’s equipment, supplies,
facilities, or trade secrets and neither related to the Company’s actual or
anticipated business, research or development, nor resulted from work performed
by me for the Company.  In the absence of
a Specific Inventions Law, the preceding sentence will not apply.

2.5          Obligation to Keep Company Informed.  During the period of my employment and for
six months after the last day of my employment with the Company, I will
promptly disclose to the Company fully and in writing all Inventions authored,
conceived or reduced to practice by me, 

 

either alone or jointly
with others.  In addition, I will
promptly disclose to the Company all patent applications filed by me or on my
behalf within a year after termination of employment.  At the time of each such disclosure, I will
advise the Company in writing of any Inventions that I believe fully qualify
for protection under the provisions of a Specific Inventions Law; and I will at
that time provide to the Company in writing all evidence necessary to
substantiate that belief.  The Company will
keep in confidence and will not use for any purpose or disclose to third
parties without my consent any confidential information disclosed in writing to
the Company pursuant to this Agreement relating to Inventions that qualify
fully for protection under a Specific Inventions Law.  I will preserve the confidentiality of any
Invention that does not fully qualify for protection under a Specific
Inventions Law.

2.6          Government or Third Party.  I also agree to assign all my right, title
and interest in and to any particular Invention to a third party, including
without limitation the United States, as directed by the Company.

2.7          Works for Hire.  I acknowledge that all original works of
authorship which are made by me (solely or jointly with others) within the
scope of my employment and which are protectable by copyright are “works made
for hire,” pursuant to United States Copyright Act (17 U.S.C., Section 101).

2.8          Enforcement of Proprietary Rights.  I will assist the Company in every proper way
to obtain, and from time to time enforce, United States and foreign Proprietary
Rights relating to Company Inventions in any and all countries.  To that end I will execute, verify and
deliver such documents and perform such other acts (including appearances as a
witness) as the Company may reasonably request for use in applying for,
obtaining, perfecting, evidencing, sustaining and enforcing such Proprietary
Rights and the assignment thereof.  In
addition, I will execute, verify and deliver assignments of such Proprietary
Rights to the Company or its designee. 
My obligation to assist the Company with respect to Proprietary Rights
relating to such Company Inventions in any and all countries shall continue
beyond the termination of my employment, but the Company shall compensate me at
a reasonable rate after my termination for the time actually spent by me at the
Company’s request on such assistance.

In the event the Company is unable for any reason,
after reasonable effort, to secure my signature on any document needed in connection
with the actions specified in the preceding paragraph, I hereby irrevocably
designate and appoint the Company and its duly authorized officers and agents
as my agent and attorney in fact, which appointment is coupled with an
interest, to act for and in my behalf to execute, verify and file any such
documents and to do all other lawfully permitted acts to further the purposes
of the preceding paragraph with the same legal force and effect as if executed
by me.  I hereby waive and quitclaim to
the Company any and all claims, of any nature whatsoever, which I now or may
hereafter have for infringement of any Proprietary Rights assigned hereunder to
the Company.

3.             NO
CONFLICTS OR SOLICITATION. I acknowledge that during
my employment I will have access to and knowledge of Proprietary
Information.  I also acknowledge that
during my employment with the Company, I have held and/or will hold a
management or executive position or am, or will be, an assistant to a manager
or executive. To protect the Company’s Proprietary Information, I agree that
during the period of my employment by the Company I will not, without the
Company’s express written consent, engage in any other employment or business
activity directly related to the business in which the Company is now involved
or becomes involved, nor will I engage in any other activities which conflict
with my obligations to the Company.  To
protect the Company’s Proprietary Information, and because of the position in
the Company that I hold, I agree that during my employment with the Company
whether full-time or part-time and for a period of one year after my last day
of employment with the Company, I will not (a) directly or indirectly solicit
or induce any employee of the Company to terminate or negatively alter his or
her relationship with the Company or (b) directly or indirectly solicit the
business of any client or customer of the Company (other than on behalf of the
Company) or (c) directly or indirectly induce any client, customer, 

 

supplier, vendor, consultant
or independent contractor of the Company to terminate or negatively alter his,
her or its relationship with the Company. 
I agree that the geographic scope of the non-solicitation should include
the “Restricted Territory” (as defined below).

4.             If any
restriction set forth in this Section 4 is found by any court of competent
jurisdiction to be unenforceable because it extends for too long a period of
time or over too great a range of activities or in too broad a geographic area,
it shall be interpreted to extend only over the maximum period of time, range
of activities or geographic area as to which it may be enforceable.

5.             COVENANT NOT TO
COMPETE.  I
acknowledge that during my employment I will have access to and knowledge of
Proprietary Information.  I also
acknowledge that during my employment with the Company, I have held and/or will
hold a management or executive position or am, or will be, an assistant to a
manager or executive.  To protect the
Company’s Proprietary Information, and because of the position in the Company
that I may hold, I agree that during my employment with the Company whether
full-time or part-time and for a period of one year after my last day of
employment with the Company, I will not directly or indirectly engage in (whether
as an employee, consultant, proprietor, partner, director or otherwise), or
have any ownership interest in, or participate in the financing, operation,
management or control of, any person, firm, corporation or business that
engages in a “Restricted Business” in a “Restricted Territory” (as defined
below).  It is agreed that ownership of
(i) no more than one percent (1%) of the outstanding voting stock of a publicly
traded corporation, or (ii) any stock I presently own shall not constitute a
violation of this provision.

5.1          Reasonable.  I agree and acknowledge that the time
limitation on the restrictions in this paragraph, combined with the geographic
scope, is reasonable.  I also acknowledge
and agree that this paragraph is reasonably necessary for the protection of
Company’s Proprietary Information as defined in paragraph 1.2 herein, that
through my employment I shall receive adequate consideration for any loss of
opportunity associated with the provisions herein, and that these provisions
provide a reasonable way of protecting Company’s business value which will be
imparted to me.  If any restriction set
forth in this Section 5 is found by any court of competent jurisdiction to be
unenforceable because it extends for too long a period of time or over too
great a range of activities or in too broad a geographic area, it shall be
interpreted to extend only over the maximum period of time, range of activities
or geographic area as to which it may be enforceable.

5.2          As used herein, the
terms:

(i)            “Restricted Business” shall mean the
development or commercialization of radiosensitizers.

(ii)           “Restricted Territory” shall mean any
state, county, or locality in the United States in which the Company conducts
business and any other country, city, state, jurisdiction, or territory in
which the Company does business.

6.             RECORDS.  I agree to keep and maintain adequate and
current records (in the form of notes, sketches, drawings and in any other form
that may be required by the Company) of all Proprietary Information developed
by me and all Inventions made by me during the period of my employment at the
Company, which records shall be available to and remain the sole property of
the Company at all times.

7.             NO CONFLICTING
OBLIGATION.  I
represent that my performance of all the terms of this Agreement and as an
employee of the Company does not and will not breach any agreement to keep in
confidence information acquired by me in confidence or in trust prior to my
employment by the Company.  I have not
entered into, and I agree I will not enter into, any agreement either written
or oral in conflict herewith.

8.             RETURN OF COMPANY
MATERIALS.  When
I leave the employ of the Company, I will deliver to the Company any and all
drawings, notes, memoranda, specifications, devices, formulas, and documents,
together with all copies thereof, and any other material containing or
disclosing any Company Inventions, Third Party Information or Proprietary
Information of the Company, unless agreed to by the Company.  I further agree that any property situated on
the Company’s premises and owned by the Company, including disks and other
storage media, filing cabinets or other work areas, is subject to inspection by
Company personnel at any time with or without notice.

 

9.             LEGAL AND
EQUITABLE REMEDIES.  Because my services are personal and unique
and because I may have access to and become acquainted with the Proprietary
Information of the Company, the Company shall have the right to enforce this
Agreement and any of its provisions by injunction, specific performance or
other equitable relief, without bond and without prejudice to any other rights
and remedies that the Company may have for a breach of this Agreement.

10.          NOTICES.  Any notices required or permitted hereunder
shall be given to the appropriate party at the address specified below or at
such other address as the party shall specify in writing.  Such notice shall be deemed given upon
personal delivery to the appropriate address or if sent by certified or
registered mail, three days after the date of mailing.

11.          NOTIFICATION OF NEW
EMPLOYER.  In
the event that I leave the employ of the Company, I hereby consent to the
notification of my new employer of my rights and obligations under this
Agreement.

12.          GENERAL PROVISIONS.

12.1        Governing Law; Consent to Personal
Jurisdiction and Exclusive Forum.  This Agreement will be governed by and
construed according to the laws of the State of Colorado as such laws are
applied to agreements entered into and to be performed entirely within Colorado
between Colorado residents.  I hereby
expressly understand and consent that my employment is a transaction of
business in the State of Colorado and constitutes the minimum contacts
necessary to make me subject to the personal jurisdiction of the state courts
and federal courts located in the State of Colorado, for any lawsuit filed
against me by Company arising from or related to this Agreement.  I agree and acknowledge that any controversy
arising out of or relating to this Agreement or the breach thereof, or any
claim or action to enforce this Agreement or portion thereof, or any
controversy or claim requiring interpretation of this Agreement must be brought
in a forum located within the State of Colorado.  No such action may be brought in any forum
outside the State of Colorado.  Any
action brought in contravention of this paragraph by one party is subject to
dismissal at any time and at any stage of the proceedings by the other, and no
action taken by the other in defending, counter claiming or appealing shall be
construed as a waiver of this right to immediate dismissal.  A party bringing an action in contravention
of this paragraph shall be liable to the other party for the costs, expenses
and attorney’s fees incurred in successfully dismissing the action or
successfully transferring the action to the state courts and federal courts
located in the State of Colorado.

12.2        Severability.  In case any one or more of the provisions
contained in this Agreement shall, for any reason, be held to be invalid, illegal
or unenforceable in any respect, such invalidity, illegality or
unenforceability shall not affect the other provisions of this Agreement, and
this Agreement shall be construed as if such invalid, illegal or unenforceable
provision had never been contained herein. 
If moreover, any one or more of the provisions contained in this
Agreement shall for any reason be held to be excessively broad as to duration,
geographical scope, activity or subject, it shall be construed by limiting and
reducing it, so as to be enforceable to the extent compatible with the
applicable law as it shall then appear.

12.3        Successors and Assigns.  This Agreement will be binding upon my heirs,
executors, administrators and other legal representatives and will be for the
benefit of the Company, its successors, and its assigns.

12.4        Survival.  The provisions of this Agreement shall
survive the termination of my employment and the assignment of this Agreement
by the Company to any successor in interest or other assignee.

12.5        Employment.  I agree and understand that my employment is
at-will which means I or the company each have the right to terminate my
employment at will, with or without advanced notice and with or without cause.  I further agree and understand that nothing
in this Agreement shall confer any right with respect to continuation of
employment by the Company, nor shall it interfere in any way with my right or
the Company’s right to terminate my employment at any time, with or without
cause.

 

12.6        Waiver.  No waiver by the Company of any breach of
this Agreement shall be a waiver of any preceding or succeeding breach.  No waiver by the Company of any right under
this Agreement shall be construed as a waiver of any other right.  The Company shall not be required to give
notice to enforce strict adherence to all terms of this Agreement.

12.7        Entire Agreement.  The obligations pursuant to Sections 1
through 8 (including all subparts) of this Agreement shall apply to any time
during which I was previously employed, or am in the future employed, by the
Company as a consultant if no other agreement governs nondisclosure and
assignment of inventions during such period. 
This Agreement is the final, complete and exclusive agreement of the
parties with respect to the subject matter hereof and supersedes and merges all
prior discussions between us.  No
modification of or amendment to this Agreement, nor any waiver of any rights
under this Agreement, will be effective unless in writing and signed by the
party to be charged.  Any subsequent
change or changes in my duties, salary or compensation will not affect the
validity or scope of this Agreement

This Agreement shall be
effective as of the August 12, 2002.

I HAVE READ THIS AGREEMENT
CAREFULLY AND UNDERSTAND ITS TERMS.  I
HAVE COMPLETELY FILLED OUT EXHIBIT A
TO THIS AGREEMENT.

	
  

  	
  Dated:

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  /s/ David A. DeLong

  
	
   

  	
  David A. DeLong

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  ACCEPTED AND AGREED TO:

  
	
   

  	
   

  	
   

  
	
   

  	
  /s/ Michael E. Hart

  

 

 

EXHIBIT A

	
  TO:

  	
  Allos Therapeutics, Inc.

  	
   

  
	
   

  	
   

  	
   

  
	
  FROM:

  	
  David A. DeLong

  	
   

  
	
   

  	
   

  	
   

  
	
  DATE:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  SUBJECT:

  	
  Previous Inventions

  	
   

  

 

1.             Except as listed in Section 2 below, the following is a
complete list of all inventions or improvements relevant to the subject matter
of my employment by Allos Therapeutics, Inc. that
have been made or conceived or first reduced to practice by me alone or jointly
with others prior to my engagement by the Company:

	
  o

  	
  No inventions or improvements.

  
	
   

  	
   

  
	
  o

  	
  See below:

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
  o

  	
  Additional sheets attached.

  

2.             Due
to a prior confidentiality agreement, I cannot complete the disclosure under
Section 1 above with respect to inventions or improvements generally
listed below, the proprietary rights and duty of confidentiality with respect
to which I owe to the following party(ies):

	
  Invention or Improvement

  	
   

  	
  Party(ies)

  	
   

  	
  Relationship

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  1.

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  2.

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  3.

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

o            Additional sheets attached.

 

EXHIBIT B

RELEASE AGREEMENT

I
understand that my position with Allos Therapeutics, Inc. (the “Company”)
terminated effective            ,
      (the “Separation Date”).  The Company has agreed that if I choose to
sign this Release, the Company will pay me certain severance benefits pursuant
to the terms of the Separation Agreement (the “Agreement”) between myself and
the Company, and any agreements incorporated therein by reference.  I understand that I am not entitled to such
benefits unless I sign this Release and it becomes fully effective.  I understand that, regardless of whether I
sign this Release, the Company will pay me all of my accrued salary and
vacation through the Separation Date, to which I am entitled by law.

In
consideration for the severance benefits I am receiving under the Agreement, I
hereby release the Company and its officers, directors, agents, attorneys,
employees, shareholders, parents, subsidiaries, and affiliates from any and all
claims, liabilities, demands, causes of action, attorneys’ fees, damages, or
obligations of every kind and nature, whether they are now known or unknown,
arising at any time prior to the date I sign this Release.  This general release includes, but is not
limited to:  all federal and state
statutory and common law claims, claims related to my employment or the
termination of my employment or related to breach of contract, tort, wrongful
termination, discrimination, wages or benefits, or claims for any form of
equity or compensation.  Notwithstanding
the release in the preceding sentence, I am not releasing any right of
indemnification I may have for any liabilities arising from my actions within
the course and scope of my employment with the Company.

If I
am forty (40) years of age or older as of the Separation Date, I acknowledge that
I am knowingly and voluntarily waiving and releasing any rights I may have
under the federal Age Discrimination in Employment Act of 1967, as amended (“ADEA”).  I also acknowledge that the consideration
given for the waiver in the above paragraph is in addition to anything of value
to which I was already entitled.  I have
been advised by this writing, as required by the ADEA that:  (a) my waiver and release do not apply to any
claims that may arise after my signing of this Release; (b) I should consult
with an attorney prior to executing this Release; (c) I have twenty-one (21)
days within which to consider this Release (although I may choose to
voluntarily execute this Release earlier); (d) I have seven (7) days following
the execution of this release to revoke the Release; and (e) this Release will
not be effective until the eighth day after this Release has been signed both
by me and by the Company (“Effective Date”).

	
  Agreed:

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  ALLOS THERAPEUTICS INC.

  	
   

  	
  DAVID A. DELONG

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Name:

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Title:

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Date:

  	
   

  	
   

  	
  Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00117-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00117-of-00352.parquet"}]]